1H-Indole-1-sulfonamide,2,3-dihydro-(9CI)
Title | Journal |
---|---|
BPR1K653, a novel Aurora kinase inhibitor, exhibits potent anti-proliferative activity in MDR1 (P-gp170)-mediated multidrug-resistant cancer cells. | PloS one 20110101 |
A novel oral indoline-sulfonamide agent, N-[1-(4-methoxybenzenesulfonyl)-2,3-dihydro-1H-indol-7-yl]-isonicotinamide (J30), exhibits potent activity against human cancer cells in vitro and in vivo through the disruption of microtubule. | The Journal of pharmacology and experimental therapeutics 20071001 |